Try it
Ophthalmology · Retina: management of central serous chorioretinopathy
Sample itemA 38-year-old man has been taking oral prednisolone for asthma. He now has painless blurring and micropsia in the right eye with a serous macular detachment on OCT and 6/9 vision. What is the most appropriate initial step?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Stop or taper the corticosteroid if possible and observe for resolution
Corticosteroid exposure is a strong risk factor for central serous chorioretinopathy. Most acute episodes resolve spontaneously over about three months, so withdrawing the steroid and observing is the first step. Laser or photodynamic therapy is kept for persistent or recurrent fluid.
Option by option
A. Perform pars plana vitrectomy with membrane peeling
Vitrectomy is for tractional and vitreous problems and is not used for serous detachment from RPE leakage.
B. Start panretinal photocoagulation of the whole retina
Panretinal photocoagulation treats retinal ischaemia and neovascularisation and has no role in a serous macular detachment.
C. Stop or taper the corticosteroid if possible and observe for resolution (correct)
Correct. Removing the steroid trigger and observing is the standard first step because most acute cases resolve.
D. Give repeated intravitreal anti-VEGF injections
Anti-VEGF injections are used for choroidal neovascularisation and macular oedema and are not first-line here.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…
- GlaucomaWhich drug is given systemically to reduce intraocular pressure in acute angle-closure g…